From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith (more bad language) Bearcast: Update on the bastards at Barclays and hard questions for SP Angel and my old pal Jim Mellon

By Tom Winnifrith | Tuesday 30 October 2018


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Warning there is plenty of bad language in the podcast - perhaps do not play it in front of the kids. I start with an update on those bastards at Barclays (BARC) who I discussed yesterday. I then look at Victoria (VCP), Jim Mellon's Port Erin (PEBI), two SP Angel dogs MySquar (FRAUD) and BjueJay Mining (JAY) and have new and serious questions for the shamed Nomad to consider. I look at Frontera (FRR) and its looming bailout placing, at Ascent Resources (AST) and at Rainbow Rare Earths (RBW). I also discuss the market sell off commending a reader who notes both my genius and my modesty on this matter.

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 06:35:21